Expression of hla-dr in cytotoxic t lymphocytes

Funding Information: Funding: This work was supported by Terry Fox Research Grant 2019 from Liga Portuguesa Contra o Cancro; Clinical Research Prize 2018 from Consortium Tagus Tank; Fundação para a Ciência e Tecnologia (PD/BD/114023/2015 for DPS and SFRH/BD/148422/2019 for RS) and iNOVA4Health (UIDB...

ver descrição completa

Detalhes bibliográficos
Autor principal: Saraiva, Diana P. (author)
Outros Autores: Azeredo-Lopes, Sofia (author), Antunes, Ana (author), Salvador, Rute (author), Borralho, Paula (author), Assis, Beatriz (author), Pereira, Isabel L. (author), Seabra, Zita (author), Negreiros, Ida (author), Jacinto, António (author), Braga, Sofia (author), Cabral, M. Guadalupe (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
3D co-cultures
Biomarker
Breast cancer
Cytotoxic T lymphocytes
HLA-DR
Immune-modulation
Neoadjuvant chemotherapy
Oncology
Cancer Research
SDG 3 - Good Health and Well-being
Texto completo:http://hdl.handle.net/10362/124267
País:Portugal
Oai:oai:run.unl.pt:10362/124267

Texto Completo

http://hdl.handle.net/10362/124267

Registos relacionados